Millennium Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Millennium Management’s Portfolio MDNA Stock Details MDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,988	Closed	-$7.14K	–	6820
2023 Q3	$7.14K	Buy	+24,988	New	+$9.71K	﹤0.01%	5816
2023 Q2	–	Sell	-68,215	Closed	-$44K	–	6934
2023 Q1	$44K	Buy	68,215 +10,656	+19%	+$6.64K	﹤0.01%	5664
2022 Q4	$27K	Buy	57,559 +45,379	+373%	+$27.7K	﹤0.01%	5975
2022 Q3	$10K	Sell	12,180 -4,188	-26%	-$4.73K	﹤0.01%	6668
2022 Q2	$19K	Buy	+16,368	New	+$17.5K	﹤0.01%	6505
2021 Q2	–	Sell	-122,488	Closed	-$500K	–	7302
2021 Q1	$500K	Buy	+122,488	New	+$499K	﹤0.01%	4826

Other funds holding MDNA

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

NDSI

Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management's MDNA Position: Q4 2023 in Review

Millennium Management sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 24,988 shares — an estimated $7.14K sold.

Millennium Management first reported a position in MDNA in Q1 2021 and held it in 6 quarters. The position peaked at $500K in Q1 2021. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

Millennium Management reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 24,988 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $7.14K.
Millennium Management first reported a position in Medicenna Therapeutics Corp. Common Shares in Q1 2021 and held it in 6 quarters.
Millennium Management's Medicenna Therapeutics Corp. Common Shares position peaked at $500K in Q1 2021.
3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.